Abstract:Background In addition to deconditioning, persistent low-grade inflammation following acute SARS-CoV-2 infection may contribute to systemic problems, which supports the need for further assessment of cardiopulmonary conditioning. In fact, the impairment of the respiratory system in the acute phase of COVID-19 has the potential to significantly impact functional capacity in patients with post-COVID-19 syndrome (PCS), with dynamic hyperinflation (DH) and reduced ventilatory reserve (RV). Objective To investigate the dynamic ventilatory responses and their influence on the functional capacity to exercise in these patients. Methods Between March and October 2022, a cross-sectional study was carried out with 16 patients with PCS aged ≥18 years attended at the Piquet Carneiro Polyclinica, at the State University of Rio de Janeiro. Patients with a history of COVID-19 pneumonia with persistence of respiratory symptoms after 3 months of the acute phase were included. Patients without a previous diagnosis of COVID-19 confirmed by RT-PCR (reverse-transcription polymerase chain reaction) and those who failed to perform the protocol tests were excluded. Patients underwent impulse oscillometry (IOS), spirometry, 6-minute walk test (6MWT) with Spiropalm®-6MWT, and cardiopulmonary exercise test (CPET). A ≥100 ml decrease in inspiratory capacity (IC) during exercise was defined as HD. Ventilatory reserve (VR) indicates how close minute ventilation (VE) approaches maximum voluntary ventilation (MVV) during a given activity and was calculated as the difference between MVV and VEpeak ([MVV-VEpeak]/MVV); VR <30% was considered to be ventilatory limitation on exertion. Results Median age and time since diagnosis of COVID-19 were 57 (50–59) years and 98 (93–106) days, respectively. Regarding spirometry, 12.5% and 50% of the participants had an abnormal spirometry and an altered IOS, respectively, and the difference in resistance between 4 Hz and 20 Hz (R4-R20) was detected in 31.2% of the participants. cases. Regarding cardiopulmonary performance during exercise, the median distance in the 6MWT was 83 (78–97) % of predicted, with HD and VR <30% observed in 62.5% and 12.5% of participants, respectively. In CPET, the median peak oxygen consumption (VO2peak) was 19 (14–37) ml/kg/min. There was a significant correlation of the distance covered in the 6MWT with both R4-R20 (rs = -0.499, P = 0.039) and VO2peak (rs = 0.628, P = 0.009). Conclusion Our findings suggest that HD and, to a lesser extent, low VR are contributors to poor exercise performance that is associated with peripheral airway disease. Implications Based on these results, we obtained precise ventilatory and metabolic measurements, which we can consider as an important factor for more assertive exercise prescription during the rehabilitation of these patients. Moreover, these results are promising if we consider that they were obtained with simple, cheap, and portable ventilatory and metabolic measurement systems, easily applicable in real-world environments.

Modelling lung diffusion-perfusion limitation in mechanically ventilated SARS-CoV-2 patients

A personalised computational model of the impact of COVID-19 on lung function under mechanical ventilation

Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies

Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study

Modulation of pulmonary blood flow in patients with acute respiratory failure

Lung Mechanics of Mechanically Ventilated Patients With COVID-19: Analytics With High-Granularity Ventilator Waveform Data

Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase

Predictive value of invasive mechanical ventilation parameters for mortality in COVID-19 related ARDS: a retrospective cohort study

Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review

Impact of ventilatory support modalities and timing of intubation on longitudinal recovery of pulmonary sequelae in critically ill Covid-19 patients

Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2

Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report

Pneumolysis and "Silent Hypoxemia" in COVID-19

Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia

Pulmonary function in patients surviving to COVID-19 pneumonia

Performance of non-invasive respiratory function indices in predicting clinical outcomes in patients hospitalized for COVID-19 pneumonia in medical and sub-intensive wards: a retrospective cohort study

Surviving Critical Care: A Follow-Up Study Assessing Pulmonary Function, Cardiopulmonary Exercise Testing, and Quality of Life in COVID-19-Affected Patients

Cardiorespiratory abnormalities in ICU survivors of COVID-19 with postacute sequelae of SARS-CoV-2 infection are unrelated to invasive mechanical ventilation

Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis.

Lung morphology changes in patients with COVID-induced acute respiratory distress syndrome depending on the respiratory therapy options

EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME